Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;5(4):424-33.
doi: 10.21037/tau.2016.06.04.

The pathophysiology of lifelong premature ejaculation

Affiliations
Review

The pathophysiology of lifelong premature ejaculation

Marcel D Waldinger. Transl Androl Urol. 2016 Aug.

Abstract

For many decades it has been thought that lifelong premature ejaculation (PE) is only characterized by persistent early ejaculations. Despite enormous progress of in vivo animal research, and neurobiological, genetic and pharmacological research in men with lifelong PE, our current understanding of the mechanisms behind early ejaculations is far from complete. The new classification of PE into four PE subtypes has shown that the symptomatology of lifelong PE strongly differs from acquired PE, subjective PE and variable PE. The phenotype of lifelong PE and therefore also the pathophysiology of lifelong PE is much more complex. A substantial number of men with lifelong PE not only have PE, but also premature erection and premature penile detumescence as part of an acute hypertonic or hypererotic state when engaged in an erotic situation or when making love. As both erectio praecox, ejaculatio praecox, detumescentia praecox, and the hypererotic state are part of the phenotype lifelong PE, it is argued that lifelong PE is not only a disturbance of the timing of ejaculation but also a disturbance of the timing of erection, detumescence and arousal. Since 1998, the pathophysiology of lifelong PE was thought to be mainly mediated by the central serotonergic system in line with genetic polymorphisms of specific serotonergic genes. However, by accepting that lifelong PE is characterized by the reversible hypertonic state the hypothesis of mainly serotonergic dysfunction is no longer tenable. Instead, it has been postulated that the pathophysiology of lifelong PE is mediated by a very complex interplay of central and peripheral serotonergic, dopaminergic, oxytocinergic, endocrinological, genetic and probably also epigenetic factors. Progress in research of lifelong PE can only be accomplished when a stopwatch is used to measure the IELT and the cut-off point of 1 minute for the definition of lifelong PE is maintained. Current use of validated questionnaires, neglect of stopwatch research, clinically inexperienced investigators and inclusion of anonymous men in a study performed by the Internet endanger the continuation of objective research of lifelong PE.

Keywords: Lifelong premature ejaculation (lifelong PE); detumescentia praecox; ejaculatio praecox; erectio praecox; genetic polymorphism; hypererotic state.

PubMed Disclaimer

Conflict of interest statement

The author has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Classification of four PE subtypes. The classification by Waldinger (28) is an extension of the original classification of Schapiro (2) and includes erectio praecox, that was originally reported by Schapiro but has been ignored for many decades. In this classification the hypertonic and hypotonic types of Schapiro have been renamed hypertonic state and hypotonic state. The two new subtypes variable PE and subjective PE are examples of a normotonic state with normal IELT values.

Similar articles

Cited by

References

    1. Gross S. Practical treatise on impotence and sterility. Edinburgh: Y.J. Pentland, 1887.
    1. Schapiro B. Premature ejaculation, a review of 1130 cases. J Urol 1943;50:374-9.
    1. Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989;15:130-4. 10.1080/00926238908403817 - DOI - PubMed
    1. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002;168:2359-67. 10.1016/S0022-5347(05)64146-8 - DOI - PubMed
    1. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151:1377-9. 10.1176/ajp.151.9.1377 - DOI - PubMed